[ad_1]
Russia is releasing misleading information intended to force Americans to question whether the United States has been in a rush to approve Pfizer’s COVID-19 vaccine, reports businessinsider.com.
“We can say that these news portals are directly related to Russia’s intelligence services,” an official from the State Department’s Center for Global Engagement told the newspaper. – They are registered outside the United States and are owned by foreign companies. The coverage, tone and audience of the portals vary widely, but they are all part of Russia’s propaganda and disinformation ecosystem. “
In November, Russian President Vladimir Putin said the country hoped to distribute the controversial Sputnik V coronavirus vaccine to other countries. Russia announced the successful development of the vaccine in August, but the circumstances of Sputnik V’s approval are in doubt. The vaccine was introduced without a third phase of studies. In the US, this step is required for the Food and Drug Administration to evaluate and approve the drug or vaccine.
The urgent action has led officials to speculate whether the Kremlin was pressuring vaccine developers to quickly complete Sputnik V in order to gain an advantage in the global race to vaccinate against the novel coronavirus.
US intelligence officials now see the Kremlin’s efforts to downplay the Pfizer vaccine as another way to boost Sputnik V’s status, according to the Wall Street Journal.
Johnson & Johnson is the latest company to introduce the COVID-19 vaccine. The healthcare giant is offering a single dose of the vaccine, which it hopes to vaccinate 4 million soon. American.
The vaccine, developed by Johnson & Johnson, was approved by the Food and Drug Administration in late February. Company representatives said they hope to vaccinate 20 million by the end of March. people, at the end of June – 100 million.
The US population is now vaccinated with three effective vaccines, including the Johnson & Johnson variant.
Pfizer and Moderna, the two companies that previously developed coronavirus vaccines after Johnson & Johnson, account for 94 percent respectively. and 95 percent. effectiveness.
It is strictly forbidden to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to indicate DELFI as the source .
[ad_2]
